The CEO of Roche Pharmaceuticals, Daniel O’Day, talks the future of biotech and how Big Data is saving lives.

It could be argued that no-one knows the importance of innovation more than the team working at Roche Pharmaceuticals. As a company that is at the forefront of fighting cancer and other diseases, its innovations in medicine and patient care dramatically benefit the lives of millions of people. In 2016, the Roche Group, the world’s largest biotech company, invested almost CHF10 billion in R&D and employed more than 94,000 people around the world.